Psychedelic therapy costs range from $3,000 for a full ketamine protocol to over $40,000 for Swiss MDMA compassionate use in 2026. The price spread reflects different pathways, not different quality tiers. Oregon psilocybin services centers charge $1,500 to $3,500 per dosing session according to Oregon Health Authority data, with total program cost landing between $3,000 and $5,000 including preparation and integration (Oregon Health Authority, 2024). Founders frequently underestimate the total by 30 to 50 percent because preparation, integration, travel, and lost workdays do not show up in clinic price lists.
The cost conversation matters because the decision is rarely about a single session. A meaningful protocol involves preparation, dosing, and an integration arc that typically runs three to six months. Total budgets vary tenfold across legal pathways. Insurance is mostly absent. Out-of-pocket payment is the rule rather than the exception. The honest question is not what does one session cost. The honest question is what does the complete decision cost, including the parts no one quotes upfront.
If you've already read about where psychedelic therapy is legal in 2026, this is the financial overlay. The legal pathways and the cost structures map closely but not identically. Ketamine is the cheapest and most accessible. Oregon psilocybin is the simplest finite spend. Australian MDMA is the most expensive legal protocol with the strongest clinical evidence base. Retreats sit outside formal legal frameworks but compete on price for clients willing to navigate that grey zone. The right answer depends on the use case, the timeline, and the budget you can absorb without strain.
- Ketamine-assisted therapy (KAP) costs $3,000 to $9,000 for a six to twelve session protocol at $400 to $800 per session. It is the cheapest legal psychedelic pathway in the United States.
- Oregon psilocybin services run $3,000 to $5,000 all-in. The Oregon Health Authority licensed 31 service centers by end of 2024 (Oregon Health Authority, 2024).
- Australia's full MDMA protocol under the TGA Authorised Prescriber scheme costs AUD 20,000 to AUD 30,000 (TGA, 2023).
- Hidden costs add 30 to 50 percent on top of session pricing: preparation, integration, medication taper, travel, and three to seven lost workdays.
- MAPS Phase 3 MDMA trials showed 67 percent of treatment-resistant PTSD participants no longer met diagnostic criteria after three sessions, durable at 18-month follow-up (MAPS, 2023). The ROI math is genuinely favorable when the alternative is years of weekly therapy.
What Does Psychedelic Therapy Actually Cost in 2026?
Total all-in cost for a complete psychedelic therapy protocol in 2026 ranges from approximately $3,000 to $40,000 depending on substance, jurisdiction, and integration depth. Most domestic US pathways land between $3,500 and $9,000. International protocols cost two to five times more. Pricing has remained roughly stable since 2023 across legal jurisdictions, with modest increases in Oregon and Colorado as licensed facilitator scarcity has eased.
The headline session prices are the easy part. A single Oregon psilocybin session is around $2,200 on average. A single ketamine infusion costs $500 to $700. A single MDMA-assisted session in Australia runs AUD 8,000 to AUD 12,000. These numbers are accurate but incomplete. They cover the dosing day and the immediate facilitation, not the surrounding architecture that determines whether the session produces lasting change.
The complete cost includes preparation meetings, the dosing session itself, immediate integration sessions, follow-up integration over three to six months, travel and lodging when relevant, and the indirect cost of lost productivity around the experience. In my practice across 900+ integration sessions, the founders who track total spend honestly land 35 to 50 percent above the headline session number. The pattern is consistent enough to plan around.
Oregon Health Authority data shows psilocybin service centers charge $1,500 to $3,500 per dosing session, with total program cost including preparation and integration meetings typically between $3,000 and $5,000 (Oregon Health Authority, 2024). Group sessions reduce per-person pricing to approximately $1,000. The OHA does not regulate pricing, so variability across the state's 31 licensed centers is significant. Insurance does not cover psilocybin services because the substance remains federally Schedule I.
Why Is Ketamine-Assisted Therapy the Cheapest Legal Entry Point?
Ketamine-assisted therapy (KAP) costs $400 to $800 per session in 2026, with a typical six to twelve session protocol totaling $3,000 to $9,000, making it the most affordable legal psychedelic pathway in the United States. Ketamine is a DEA Schedule III substance, the lowest restriction tier of any psychedelic with therapeutic application (DEA, 2024). Any licensed US physician can prescribe it off-label. Clinics operate in all 50 states.
IV Infusion vs Lozenge vs Spravato Pricing
IV ketamine infusions cost $400 to $800 per session and run 40 to 60 minutes. Intramuscular injections fall in a similar range. Sublingual lozenges, often used in at-home protocols supervised by telehealth providers, run $250 to $500 per dose. Spravato (esketamine nasal spray) costs $500 to $900 per session at the clinic price, but it is covered by many insurance plans for treatment-resistant depression. This is the only psychedelic pathway with meaningful insurance coverage in 2026.
A standard depression protocol uses six infusions over two to three weeks, followed by maintenance sessions at decreasing frequency. For PTSD and trauma work, the protocol typically runs eight to twelve sessions over four to six weeks. The total session count drives the spread between the $3,000 floor and the $9,000 ceiling. Most founders in my practice land at $5,000 to $7,000 for the dosing component alone.
The Integration Cost Most Ketamine Clinics Skip
Ketamine clinics are clinical facilities, not integration practices. They administer the substance safely and monitor vitals. They rarely include structured integration support. This is the gap that determines whether the protocol produces durable behavioral change or fades into the background within weeks. Standalone integration therapy with a trained psychedelic-informed therapist costs $150 to $300 per session.
A complete KAP protocol including six to twelve dosing sessions plus six to twelve integration sessions typically lands at $5,000 to $12,000 all-in. Ketamine integration work follows the same neuroplasticity-window logic that applies to longer-acting psychedelics. The dosing days create implicit memory updating capacity. The integration work converts that capacity into lasting change. Treating them as separate budget lines is the difference between a real protocol and a series of unconnected infusions.
How Much Does Psilocybin Therapy Cost in Oregon and Colorado?
Oregon psilocybin services charge $1,500 to $3,500 per dosing session in 2026, with total program cost between $3,000 and $5,000 all-in. Colorado healing centers run slightly higher at $1,800 to $3,800 per session, with all-in program costs between $4,000 and $6,000 according to Colorado Department of Revenue licensing data and provider surveys (Colorado DOR, 2024). Neither state regulates pricing, so variability across centers is meaningful.
Oregon Measure 109 Service Center Pricing
Oregon was the first US state to operationalize legal psilocybin services under Measure 109. The Oregon Health Authority licensed 31 service centers and over 290 facilitators by end of 2024. Pricing varies by format. Individual one-on-one sessions cost $2,500 to $3,500 plus preparation and integration meetings at $150 to $250 each. Group sessions of two to four people reduce per-person pricing to $1,000 to $1,500 plus shared preparation and integration components.
Total program cost in Oregon for a single full-dose experience including preparation and integration lands at $3,000 to $5,000 for most clients. Multi-session protocols, sometimes recommended for trauma-coded use cases, run proportionally higher. Oregon residency is not required. Out-of-state and international clients can legally access sessions by traveling to Oregon. Travel and lodging typically add $1,500 to $3,500 per trip, which matters for the all-in math.
Colorado Natural Medicine Program Pricing
Colorado's program under Proposition 122 activated in 2024 and operates through licensed healing centers. The Colorado Department of Revenue Natural Medicine Division oversees licensing. Pricing is comparable to Oregon with slight premiums of 10 to 20 percent at individual sessions. The program permits some home-based facilitated experiences in approved contexts, which Oregon does not, expanding format flexibility.
Healing center density in Colorado is lower than Oregon as of 2026. Wait times run six to fourteen weeks at most established centers, longer than Oregon's three to ten weeks. The licensed facilitator pool is still growing relative to demand. New Mexico's medical psilocybin program under SB 27 began accepting patients in 2025 but is narrower in target population, requiring documented PTSD, treatment-resistant depression, or end-of-life distress for access. Pricing in New Mexico is still developing in 2026.
What Do International Pathways and Retreats Cost?
Australia's MDMA-assisted therapy protocol under the TGA Authorised Prescriber scheme costs AUD 20,000 to AUD 30,000 for the full three-dose protocol, approximately USD 13,000 to USD 20,000 at 2026 exchange rates (TGA, 2023). Switzerland's compassionate use program runs CHF 20,000 to CHF 40,000. International retreats in Mexico, Peru, Costa Rica, and Jamaica span $3,000 to $15,000 plus flights. Each pathway has different documentation, legality, and integration implications that the price alone does not capture.
Australia MDMA Protocol: AUD 20-30K
Australia became the first country to legalize MDMA prescribing on July 1, 2023 through the TGA Authorised Prescriber scheme. A complete protocol includes psychiatric assessment, three dosing sessions, preparation meetings, and integration sessions across approximately three months. Pricing reflects the regulatory load. Each dosing session involves a licensed psychiatrist and a co-therapist for eight to ten hours, plus monitoring infrastructure. Private health insurance generally does not cover the dosing component.
Practical considerations for American clients include visa, travel time, and clinic capacity. The Authorised Prescriber list is publicly maintained but small relative to demand. Two trips to Australia are typical: an initial consultation and assessment trip, followed by a treatment trip of two to three weeks for full protocol completion. Travel and lodging add USD 5,000 to USD 10,000 to the protocol cost. Total all-in spend for Americans pursuing Australian MDMA therapy commonly lands at USD 25,000 to USD 35,000.
Switzerland Compassionate Use: CHF 20-40K
Switzerland operates a compassionate use program under Section 8(5) of the Narcotics Act, expanded substantially in recent years. Several Swiss psychiatric practices in Zurich, Bern, and Basel have established workflows for international patients. Cost for a full MDMA or psilocybin protocol typically lands at CHF 20,000 to CHF 40,000 (approximately USD 22,000 to USD 44,000). The program requires documented treatment resistance, which rules it out for general exploratory use.
Retreat Pricing: Mexico, Peru, Costa Rica, Jamaica
Retreat pricing spans a wide range and sits in a different legal category than the pathways above. Most retreat destinations operate under religious-use, indigenous, or legal-grey-zone frameworks rather than formal medical legalization. Mexico ayahuasca and psilocybin retreats run $2,500 to $8,000 for five to seven days. Peru ayahuasca retreats cost $1,500 to $5,000 plus flights. Costa Rica wellness retreats land at $3,000 to $10,000. Jamaica psilocybin retreats cost $3,000 to $12,000.
Higher-end retreats with credentialed medical staff, licensed therapists, and structured integration support cost $8,000 to $15,000. The price spread reflects very different quality and safety profiles. Vetting a psychedelic retreat properly is the difference between a $4,000 spend with real value and a $4,000 spend with no integration support and no medical screening. Cheap is not always cheap when the post-experience integration window is unsupported.
Pricing reflects market data as of May 18, 2026 from named regulatory and provider sources. Actual costs vary by clinic, facilitator, and exchange rate. This article is not legal or medical advice; verify current pricing, legality, and clinical fit with qualified counsel and licensed providers before booking.
What Are the Hidden Costs Most Founders Miss?
Hidden costs typically add 30 to 50 percent on top of the session pricing quoted by clinics and retreat centers. The most expensive omission is integration. The second most expensive is the realistic accounting of lost workdays. Psychology Today provider surveys put US integration therapy pricing at $150 to $300 per session in 2026 (Psychology Today, 2024). Six to twelve integration sessions, often recommended after a single high-dose experience, can therefore add $1,000 to $3,600 to any pathway's headline cost.
Preparation Meetings: $300-1,200
Most legal pathways require preparation meetings before the dosing session. Oregon service centers typically include one to two preparation meetings in the base price, but additional sessions cost $150 to $300 each. Australian and Swiss protocols require multiple psychiatric assessments and prep meetings totaling four to eight hours. KAP clinics sometimes skip formal preparation entirely, which then needs to be filled in by an outside integration therapist at additional cost.
Integration Sessions: $1,000-3,600
Integration is the line item that determines whether the session produces lasting behavioral change or fades within weeks. Six to twelve sessions at $150 to $300 each is the realistic protocol for trauma-adjacent work. Lighter use cases sometimes complete in three to six sessions at $450 to $1,800 total. Finding a properly trained integration therapist at the lower end of that pricing range requires effort, and the quality variance is meaningful.
Travel and Lost Workdays: $2,000-10,000
Travel adds significantly for any out-of-state or international pathway. Flights and hotels for Oregon, Colorado, Australia, or Switzerland add $1,500 to $5,000 per trip. International protocols typically require two trips, doubling that line item. Lost workdays during the experience and immediate integration window total three to seven days for most founders. For founders billing time at $300 to $1,000 per hour effective rates, the opportunity cost is real even when the calendar absorbs it.
Medication Tapering and Follow-Up
SSRIs and several other psychiatric medications interact with psilocybin and MDMA, requiring a supervised taper before treatment. A taper consultation runs $200 to $500 with a prescriber. Follow-up sessions at 30, 60, and 90 days post-dosing are commonly recommended. Optional somatic therapy, bodywork, or coaching extends the integration arc and adds $500 to $3,000 over the following months. The honest total cost line is rarely the line quoted on the clinic homepage.
The cost comparison between psychedelic therapy and conventional treatment is incomplete without accounting for treatment duration. SSRIs for treatment-resistant depression averages $1,200-2,400 annually with 50-60% response rate (STAR*D, n=2876); over 5 years, total cost reaches $6-12K with ongoing maintenance required. A single psilocybin protocol at $3-5K in Oregon achieving the Goodwin 2022 NEJM 29% sustained remission rate is finite-cost. The Australia MDMA program at AUD 20-30K is more expensive upfront but shows 71.2% loss of PTSD diagnosis in MAPP2 (Mitchell 2023). For founders comparing executive coaching at $300-1000/session over years, the psychedelic protocol cost is concentrated and front-loaded but operationally distinct: an event-based intervention rather than ongoing maintenance.
How Do the Six Pathways Compare on Cost and Value?
The six main pathways differ in headline cost, all-in cost, evidence base, and substance availability. No single pathway is optimal for every use case: ketamine is the lowest cost and most accessible, Oregon psilocybin is the simplest finite spend with the strongest US legal protection, Australia MDMA has the strongest clinical evidence for trauma, Switzerland combines high clinical standards with substance breadth, and retreats span quality and price extremes. The matrix below summarizes the operational differences across pathways.
| Pathway | Session Cost | All-In Total | Sessions | Hidden Costs | Insurance |
|---|---|---|---|---|---|
| KAP (Ketamine) | $400 - $800 | $3,000 - $9,000 | 6 - 12 | Integration $1-3.6K | Spravato partial |
| Oregon Psilocybin | $1,500 - $3,500 | $3,000 - $5,000 | 1 - 3 | Travel $1.5-3.5K | None |
| Colorado Psilocybin | $1,800 - $3,800 | $4,000 - $6,000 | 1 - 3 | Travel $1.5-3.5K | None |
| Australia MDMA | AUD 8,000 - 12,000 | AUD 20,000 - 30,000 | 3 dosing | Travel USD 5-10K | Rarely |
| Switzerland | CHF 5,000 - 10,000 | CHF 20,000 - 40,000 | 2 - 4 dosing | Travel $3-6K | Partial private |
| Retreats (intl) | n/a (package) | $3,000 - $15,000 | 2 - 6 over 5-10 days | Flights $1-3K | None |
| Integration only | $150 - $300 | $900 - $3,600 | 6 - 12 | Minimal | Often covered |
The matrix reveals what headline session pricing alone misses. KAP looks expensive per session but lands at the lowest all-in cost because protocols are local and integration can be billed under mental health benefits. Oregon psilocybin looks cheap per session but adds meaningful travel cost for non-residents. Australia MDMA looks expensive per session and the all-in math confirms it, with the offset being the strongest clinical evidence base of any pathway. Retreats span the widest quality range, with the price spread reflecting genuine differences in safety, integration depth, and facilitator training.
MAPS Phase 3 MDMA-assisted therapy trials for treatment-resistant PTSD reported that 67 percent of participants no longer met diagnostic criteria after three dosing sessions, with results durable at 18-month follow-up (MAPS, 2023). The trial protocol matches the Australian Authorised Prescriber pathway in 2026. Cost for the full Australian protocol at AUD 20,000 to AUD 30,000 reflects the clinical labor density: each dosing day involves a psychiatrist and co-therapist for eight to ten hours plus monitoring infrastructure.
Is Psychedelic Therapy Worth the Cost Compared to Traditional Options?
Traditional weekly psychotherapy in major US cities costs $200 to $400 per session, with average client lifetime value of approximately $20,000 across years of treatment according to American Psychological Association outcome research (APA, 2023). Executive coaching for founders runs $300 to $1,000 per session with similar long-tail costs. The ROI question depends on whether a finite psychedelic protocol produces outcomes that ongoing weekly therapy would otherwise pursue. For trauma-coded conditions, the clinical evidence increasingly favors the finite protocol.
Compare the math directly. Two years of weekly psychotherapy at $300 per session totals $31,200 before considering psychiatric medication, occasional intensive workshops, and indirect costs. A complete Oregon psilocybin protocol with integration costs $5,000 to $8,000 all-in. A complete Australian MDMA protocol costs $25,000 to $35,000 all-in including travel. A complete KAP protocol with integration costs $5,000 to $12,000. The finite protocols look favorable on cost alone when the alternative is years of weekly therapy.
"The founders who treat psychedelic therapy as a finite capital expenditure with a defined integration arc consistently land better outcomes than founders who treat it as a luxury experiment. The cost question and the outcome question are the same question."
The honest caveat is that finite protocols only outperform ongoing therapy when the integration work actually happens. Without integration, a $25,000 Australian MDMA protocol can produce a meaningful experience that fades within months, while a $300-per-session psychotherapist would have continued to deliver weekly traction. The cost comparison favors psychedelic protocols when the integration arc is real, the use case has a defined therapeutic target, and the post-experience window is genuinely worked. The cost comparison is less favorable for general wellness exploration without a defined target.
Executive coaching pricing surfaces a different angle. Founders routinely pay $500 to $1,000 per hour for coaching that addresses surface-layer business problems without touching the underlying patterns that drive those problems. A complete KAP protocol costs roughly what twelve to twenty-four hours of high-end executive coaching costs. The protocol addresses substrate-level patterns that coaching cannot reach. This is the comparison most founders find clarifying once they sit with it honestly.
Whatever pathway makes financial sense, the integration work is the line item that determines durable return on the spend. Legal access creates the conditions for change. Integration converts those conditions into lasting behavioral updates. The two budget lines are inseparable in practice, although they are routinely treated separately in clinic offerings and in coverage. Finding the right integration therapist deserves the same budget rigor as choosing the dosing pathway. The financial case for the protocol stands or falls on that single line.